Trial intelligence / Profile preview

Remifentanil for i-gel vs LMA insertion during propofol anesthesia

NCT02382354Phase 4Completed

Sponsor
Ajou University School of Medicine
Start
Mar 2015
Primary completion
Sep 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised trial of remifentanil, sponsored by Ajou University School of Medicine. Primary endpoint: Successful insertion of i-gel and LMA. Started Mar 2015; status: completed.

02

Drugs

remifentanil

Beyond the preview

Go deeper on NCT02382354.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02382354.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call